Treatment of metastatic refractory colorectal cancer following regorafenib failure

At present, there is no set strategy for the treatment of patients with colorectal cancer subsequent to the failure of standard treatment, other than the use of regorafenib (RGR) and TAS-102. The best order in which to use these drugs, and their safety and efficacy in combination with other drugs, a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Clin Oncol
Huvudupphovsmän: Takeuchi, Nobumichi, Koike, Kumiko, Yoshida, Sonomi, Kudo, Akiko, Sekiguchi, Nodoka, Nakayama, Ataru, Kubota, Kouji, Rokuhara, Takashi, Kitahara, Masayuki
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2017
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5532698/
https://ncbi.nlm.nih.gov/pubmed/28781808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1307
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk